Cargando…
The challenges and promises of new therapies for cystic fibrosis
Therapeutic intervention in cystic fibrosis (CF) remains a challenge, partly because of the number of organs and tissues affected by the lack of a functional cystic fibrosis transmembrane conductance regulator (CFTR) protein. CF was originally regarded primarily as a gastrointestinal (GI) disease be...
Autor principal: | Pier, Gerald B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Rockefeller University Press
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3444306/ https://www.ncbi.nlm.nih.gov/pubmed/22753926 http://dx.doi.org/10.1084/jem.20121248 |
Ejemplares similares
-
The Gut-Lung Axis in Cystic Fibrosis
por: Price, Courtney E., et al.
Publicado: (2021) -
Cystic fibrosis associated liver disease in children
por: Valamparampil, Joseph J, et al.
Publicado: (2021) -
Pluripotent stem cells for disease modeling and drug screening: new perspectives for treatment of cystic fibrosis?
por: Martin, Ulrich
Publicado: (2015) -
Focus on gastroesophageal reflux disease in patients with cystic fibrosis
por: Bongiovanni, Annarita, et al.
Publicado: (2020) -
Ecological Succession of Polymicrobial Communities in the Cystic Fibrosis Airways
por: Khanolkar, Rutvij A., et al.
Publicado: (2020)